Navigation Links
Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
Date:5/2/2008

BOSTON, May 2 /PRNewswire/ -- Replikins Ltd. has found that the replikin concentration of West Nile Virus increased annually through two distinct cycles as the virus expanded in the U.S.: the first from 2000 to 2003, and the second from 2004 to 2007 (p less than 0.001). Increases in the annual number of human cases followed each of the virus replikin concentration increases.

Replikins are peptides, specified in virus genomes, which increase in concentration signaling rapid replication before virus outbreaks. This is the first report that cyclic increases in virus replikin concentration, each apparently building on the last, can be a mechanism of virus expansion into a territory.

In the present study, virus ReplikinCount(TM) determined by FluForecast(TM) software was correlated with CDC epidemiological data on the number of human cases per year. Discrete cycles were distinguished within, and correlated between, virus chemistry and host morbidity. The mosquito-borne West Nile virus, which apparently incubates between seasons, has been found to increase its concentration of Replikins before the next annual step in the cycle of expansion.

This demonstration of replikin cycles represents further "proof of principle" on the relationship of replikins to virus epidemics, and a new means of discerning the course of an epidemic. Previously, increases in the ReplikinCount of the Replikins Peak Gene were found to precede and to predict outbreaks and lethality of two other viruses, influenza H5N1 and Taura Syndrome Virus, in two hosts, human and shrimp respectively. The conservation of specific replikin structures over many years, the detection of new replikins, and the chemical synthesis of replikin vaccines in 7 days, demonstrated for H5N1 and Taura Syndrome viruses, have now also been demonstrated for West Nile Virus.

For further information, Google "replikins," and see U.S. Patent Office publications.

Contact:

Replikins Ltd., 38 The Fenway, Boston MA 02215

email: sbogoch@replikins.com

Tel: 646-320-5910

http://www.Replikins.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Replikins Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
2. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
3. Demand for VScan Dengue Fever Test Kits Increases
4. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
5. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
6. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
7. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
8. New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
9. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
10. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
11. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics ... Dallas, Texas , has received notice from ... National Institutes of Health (NIH) that it has been ... grant totaling over $650,000 in 2017 with an additional ... CerSci,s Investigational New Drug application of their lead non-opioid ...
(Date:7/28/2017)... CHICAGO, July 28, 2017 Hill-Rom Holdings, Inc. ... fiscal third quarter ended June 30, 2017, and updated ... For the fiscal third quarter, ... to $0.68 per diluted share in the prior-year period. ... of $0.39 per diluted share primarily related to the ...
(Date:7/26/2017)... -- E.I. Medical Imaging (EIMI) has partnered with Dr. ... the worlds first ultrasound system to be used underwater to ... In preparation for a piece produced by Icon films ... Guttridge approached EIMI with the idea of an underwater ultrasound ... underwater. EIMI produces ...
Breaking Medicine Technology:
(Date:8/21/2017)... ... , ... PracticeMatch, a company that provides online resources , job ... practitioners like nurse practitioners and physician assistants , will conduct its ... year. The online career fairs will allow job seekers to connect with healthcare employers ...
(Date:8/21/2017)... ... August 21, 2017 , ... Los Angeles area ... fellows for academic year 2017-2018, Christina M. Busuito, M.D. and Lukasz Swistun, M.D. ... in Plastic and Reconstructive Surgery. The candidate will have the opportunity to ...
(Date:8/21/2017)... ... August 21, 2017 , ... Five chefs from local senior ... Alzheimer’s Family Center. , Guests will be able to vote for their favorite ... Lamb Shank with Fennel Dill Salad, Feta Cheese Sauce & Garlic Pita Crisp, Greek ...
(Date:8/21/2017)... , ... August 21, 2017 , ... The experts have ... are we supposed to get things done in a healthy way these days? FlexiSpot, ... launching a crowdfunding campaign on August 28 to introduce Deskcise Pro™– the world’s first ...
(Date:8/21/2017)... ... August 21, 2017 , ... San Diego physician and surgeon ... reform plan, has announced his candidacy for the 52nd Congressional District currently held by ... America’s Promise. Coming to this country at age eleven after suffering homelessness and hardship ...
Breaking Medicine News(10 mins):